Volunteer characteristics
| Patients . | Sex . | Age, y . | Duration of disease, y . | Clinical manifestations . | HTLV-1 proviral load* . | Route of infection . |
|---|---|---|---|---|---|---|
| 1 | F | 64 | 7 | HAM/TSP + Sjögren syndrome | 7.21 | Sexual |
| 2 | F | 55 | 1 | HAM/TSP + ATLL + uveitis | 21.43 | Transfusion |
| 3 | M | 45 | 2 | HAM/TSP | 5.91 | Breast-feeding |
| 4 | M | 44 | 1 | HAM/TSP | 3.39 | — |
| 5 | F | 69 | 3 | HAM/TSP + uveitis + ATLL | 9.58 | — |
| 6 | M | 37 | 3 | HAM/TSP + uveitis + ATLL + myositis | 6.49 | — |
| 7 | F | 58 | 3 | HAM/TSP | 15.54 | Transfusion |
| 8 | F | 45 | — | asymptomatic | 1 | — |
| 9 | F | 63 | 4 | HAM/TSP + myositis | 14.09 | — |
| 10 | F | — | asymptomatic | 0.75 | Breast-feeding | |
| 11 | M | 78 | 17 | HAM/TSP | 17.68 | Transfusion |
| 12 | M | 47 | 20 | HAM/TSP | 25.98 | Sexual |
| 13 | M | 38 | 5 | HAM/TSP | 9.28 | — |
| 14 | M | 62 | 7 | HAM/TSP | 4.62 | Sexual |
| 15 | M | 45 | 10 | HAM/TSP | 5.65 | — |
| 16 | M | 48 | 2 | HAM/TSP | 1.22 | — |
| 17 | F | 63 | — | asymptomatic | 5.42 | Sexual |
| 18 | F | 21 | 2 | HAM/TSP | 14.15 | Breast-feeding |
| 19 | M | 49 | 5 | HAM/TSP | 11.09 | — |
| 20 | F | 61 | 5 | HAM/TSP | 7.38 | Sexual |
| 21 | F | 68 | 3 | HAM/TSP | 2.54 | — |
| 22 | F | 64 | 8 | HAM/TSP | 0.75 | Sexual |
| 23 | F | 74 | 9 | HAM/TSP + peripheral neuropathy | 17.24 | Sexual |
| 24 | M | 43 | 4 | HAM/TSP | 7.63 | Sexual |
| 25 | F | 60 | 21 | HAM/TSP | 4.32 | Sexual |
| 26 | F | 64 | — | asymptomatic | 1.81 | Sexual |
| 27 | M | 60 | — | OLS | 6.58 | Sexual |
| Patients . | Sex . | Age, y . | Duration of disease, y . | Clinical manifestations . | HTLV-1 proviral load* . | Route of infection . |
|---|---|---|---|---|---|---|
| 1 | F | 64 | 7 | HAM/TSP + Sjögren syndrome | 7.21 | Sexual |
| 2 | F | 55 | 1 | HAM/TSP + ATLL + uveitis | 21.43 | Transfusion |
| 3 | M | 45 | 2 | HAM/TSP | 5.91 | Breast-feeding |
| 4 | M | 44 | 1 | HAM/TSP | 3.39 | — |
| 5 | F | 69 | 3 | HAM/TSP + uveitis + ATLL | 9.58 | — |
| 6 | M | 37 | 3 | HAM/TSP + uveitis + ATLL + myositis | 6.49 | — |
| 7 | F | 58 | 3 | HAM/TSP | 15.54 | Transfusion |
| 8 | F | 45 | — | asymptomatic | 1 | — |
| 9 | F | 63 | 4 | HAM/TSP + myositis | 14.09 | — |
| 10 | F | — | asymptomatic | 0.75 | Breast-feeding | |
| 11 | M | 78 | 17 | HAM/TSP | 17.68 | Transfusion |
| 12 | M | 47 | 20 | HAM/TSP | 25.98 | Sexual |
| 13 | M | 38 | 5 | HAM/TSP | 9.28 | — |
| 14 | M | 62 | 7 | HAM/TSP | 4.62 | Sexual |
| 15 | M | 45 | 10 | HAM/TSP | 5.65 | — |
| 16 | M | 48 | 2 | HAM/TSP | 1.22 | — |
| 17 | F | 63 | — | asymptomatic | 5.42 | Sexual |
| 18 | F | 21 | 2 | HAM/TSP | 14.15 | Breast-feeding |
| 19 | M | 49 | 5 | HAM/TSP | 11.09 | — |
| 20 | F | 61 | 5 | HAM/TSP | 7.38 | Sexual |
| 21 | F | 68 | 3 | HAM/TSP | 2.54 | — |
| 22 | F | 64 | 8 | HAM/TSP | 0.75 | Sexual |
| 23 | F | 74 | 9 | HAM/TSP + peripheral neuropathy | 17.24 | Sexual |
| 24 | M | 43 | 4 | HAM/TSP | 7.63 | Sexual |
| 25 | F | 60 | 21 | HAM/TSP | 4.32 | Sexual |
| 26 | F | 64 | — | asymptomatic | 1.81 | Sexual |
| 27 | M | 60 | — | OLS | 6.58 | Sexual |
F indicates female; M, male; HAM/TSP, myelopathy/tropical spastic paraparesis; ATLL, adult T-cell leukemia/lymphoma; and OLS, oligosymptomatic disease.
Number of infected leukocytes/100.